From January to September 2026, the Krka Group generated revenue of €1,660 million, up 8% year on year, yielding €364.2 million net profit, a 13% increase on the same period last year. The Supervisory Board of Krka discussed the January to September 2026 interim report for the Krka Group and Krka, d. d., at its regular meeting yesterday.
President of the Management Board and Chief Executive Officer Jože Colarič stated on the occasion: ‘The Krka Group’s successful business performance continued in the third quarter of this year. We increased product and service sales in five sales regions and most of our markets. Revenue amounted to €1,660 million, an 8% year-on-year increase. All our key business performance measures also increased. EBITDA increased by 21% to €527.9 million, while EBITDA margin reached 31.8%. EBIT totalled €455.5 million, up 24% year on year, while net profit surpassed €364 million, a 13% increase on the same period last year.
The achieved results demonstrate that we have been successfully implementing our long-term strategy founded on in-house development, innovation, operational excellence, and the ability to respond quickly to changes in the international environment. We earmarked €87.3 million for investments, a 31% year-on-year increase, and allocated 9.1% of revenue to research and development, which places us among the most research-intensive generic pharmaceutical companies. The continued roll-out of our new products and life-cycle management of existing products help us strengthen our competitiveness and enhance product availability. We added ten new products to our diverse product portfolio, which serves as the foundation for our long-term stable growth and good business results.
Considering our performance in the first three quarters, we expect to surpass our 2026 targets and create revenue of €2,179 million and net profit of €439 million. We have also informed the Supervisory Board on our 2027 business plan. The plan projects a further increase in revenue, reaching €2,308 million, and net profit of €474 million. The performance estimate and the business plan agree with the long-term Krka Group Development Strategy.’
Financial highlights
| € thousand | Index | ||
| Revenue | 1,660,036 | 1,534,028 | 108 |
| – Of which revenue from sales of products and services | 1,652,775 | 1,529,127 | 108 |
| Gross profit | 1,009,859 | 884,852 | 114 |
| Earnings before interest, tax, depreciation and amortisation (EBITDA) | 527,942 | 436,734 | 121 |
| Operating profit (EBIT) | 455,531 | 367,154 | 124 |
| Profit before tax (EBT) | 451,088 | 395,453 | 114 |
| Net profit | 364,221 | 323,654 | 113 |
| R&D expenses | 150,457 | 143,733 | 105 |
| Investments | 87,322 | 66,742 | 131 |
Performance ratios
| Gross profit margin | 60.8% | 57.7% |
| EBITDA margin | 31.8% | 28.5% |
| EBIT margin | 27.4% | 23.9% |
| EBT margin | 27.2% | 25.8% |
| Net profit margin (ROS) | 21.9% | 21.1% |
| Return on equity (ROE) | 20.2% | 19.0% |
| Return on assets (ROA) | 15.8% | 14.8% |
| Liabilities/Equity | 0.272 | 0.287 |
| R&D expenses/Revenue | 9.1% | 9.4% |
Sales
Estimated Product and Service Sales by Region
Region Slovenia,6.3
Region South-East Europe,14.3
Region East Europe,36.7
Region Central Europe,22.7
Region West Europe,16.1
Region Overseas Markets,3.9
RELATED CONTENT
Press release: Krka Reports January to September 2026 Business Results (12. 11. 2026)January to September 2026 unaudited interim report of the Krka group and Krka